Call for Abstract
21st Annual European Pharma Congress, will be organized around the theme “Advancing the future of Pharma”
Pharma Europe 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pharma Europe 2019
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Pharmacognosy is the study of drugs derived from Plants and herbs and the other aspect of Pharmacognosy is Phytochemistry. The Drugs from natural sources can be obtained by the help of following methods like Computational chemistry, Medicinal chemistry, Molecular drug design, Protein structure prediction, molecular simulation, and exploratory development and Biochemistry.
Global sales of plant products was totally estimated us $60 billion in 2002 and is expected to get higher at 6.4 % average growth rate
- Track 1-1Pharmaceutical services
- Track 1-2Packaging for Patient Compliance
- Track 1-3Drugs from natural sources
- Track 1-4Computational chemistry
- Track 1-5Molecular drug design
- Track 1-6Structure aided and computer aided drug design
- Track 1-7Telemedicine
The drug market was valued at nearly $5.8 billion during 2011 and will reach nearly $5.7 billion during 2012. Total value is expected to reach nearly $5.4 billion in 2017
- Track 2-1Cognitive neuroscience and neurosystems
- Track 2-2Cardiovascular Pharmacology
- Track 2-3Ethnopharmacology
- Track 2-4Behavioral pharmacology
- Track 2-5Medical Pharmacology
- Track 2-6Pharmacokinetics
- Track 2-7Clinical pharmacology
- Track 2-8Endocrine pharmacology
- Track 2-9Functional modes of the brain
- Track 2-10Neuropsychology
Drugs & Regulations are very important in aspects of Pharmaceutical sciences where it deals with Drug safety, Cost effectiveness, Drug rediscovery, Pharmaceutical services, Role of pharmacists, Radio Pharmaceuticals and Multiple drug use etc. The regulation of drugs varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency. In other jurisdictions they are regulated at the state level, or at both state and national levels by various bodies, as is the case in Australia.
- Track 3-1Role of pharmacists
- Track 3-2Drug safety
- Track 3-3 Implimentation of pharmacogenetics in USA
- Track 3-4Health care management and providers
- Track 3-5Clinical Pharmacy Services: patient compliance
- Track 3-6Regulations and organizations
- Track 3-7Regulatory Affairs
- Track 3-8Good governance in pharmacy
- Track 3-9Online pharmacies
- Track 3-10Multiple drug use
- Track 3-11Multiple drug use
- Track 3-12Halal medication
- Track 3-13Drug rediscovery
Practically speaking, it involves chemical aspects of identification, and then systematic, thorough synthetic alteration of new chemical entities to make them suitable for therapeutic use. It includes synthetic and computational aspects of the study of existing drugs and agents in development in relation to their bioactivities i.e., understanding their structure-activity relationships (SAR). Pharmaceutical chemistry is focused on quality aspects of medicines and aims to assure fitness for purpose of medicinal products.
- Track 4-1Protein structure prediction and molecular simulation
- Track 4-2Biochemistry
- Track 4-3Exploratory development
- Track 4-4Phytotherapy & Complementary medicine
- Track 4-5Protein structure prediction and molecular simulation
Pharmaceutical formulations, in pharmaceutics, is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. The word formulation is often used in a way that includes dosage form. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally taken drugs, this usually involves incorporating the drug into a tablet or a capsule.
- Track 5-1Oral drugs
- Track 5-2Parental Formulations
- Track 5-3Topical Formulations
- Track 5-4Modified release Formulations
- Track 5-5Modified release Formulations
- Track 5-6Modified release Formulations
- Track 5-7Novel Drug Formulations
- Track 5-8Oncological Formulations
Sometimes called, molecular manufacturing is a branch of engineering that deals with the design and manufacture of extremely small electronic circuits and mechanical devices built at the molecular level of matter. Nanotechnology is also being applied to or developed for application to a variety of industrial and purification processes. Purification and environmental clean-up applications include the desalination of water, water filtration, wastewater treatment, groundwater treatment, and other nanoremediation.
- Track 6-1Nanobiomaterials and biopharmaceuticals
- Track 6-2Nano-drugs
- Track 6-3Nanotechnology and clinical applications
- Track 6-4Nanotechnology in medicine and drug delivery imaging
- Track 6-5Nanotechnology in medicine and in targeted drug delivery
- Track 6-6Nanomedicines
- Track 6-7Nanotechnology in cancer research
- Track 6-8Pharmaceutical engineering
- Track 6-9Bionanotechnology and BioMEMS
- Track 6-10Bionanotechnology and BioMEMS
- Track 6-11 Nano-mechanisms for molecular Systems
The method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit at all. On the other hand, the very slow progress in the efficacy of the treatment of severe diseases, has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues.
- Track 7-1Liposomes
- Track 7-2 Other Novel Vesicular Herbal Formulations
- Track 7-3Liquid Crystals
- Track 7-4Liquid Crystals
- Track 7-5Liquid Crystals
- Track 7-6Liquid Crystals
- Track 7-7Liquid Crystals
- Track 7-8 Phonophoresis
- Track 7-9 Lontophoresis
- Track 7-10Chronotherapeutics
- Track 7-11Drug Loaded Erythrocytes
- Track 7-12Dendrimers
- Track 7-13Demerits
- Track 7-14Gold Nanoparticles
- Track 7-15Nanoparticles
- Track 7-16Hydrogels
- Track 7-17ProPrietary Novel Drug Delivery System of Plant Actives and Extracts
The drug discovery starts with Pre-formulation Studies which is initiated by Disease Identification then carried onto suitable drug identification then after Stability Analysis of Drug, Behavioural Analysis, Dissolution, High Performance Liquid Chromatography or Nuclear Magnetic Resonance (NMR) as per the ICH guidelines.
- Track 8-1Drug Discovery and Design
- Track 8-2Oncological Formulations
- Track 8-3Pharmaceutics and Drug Delivery
- Track 8-4Radiopharmaceuticals
- Track 8-5Routes of drug administration
- Track 8-6Fundamental Drug Development and Design
- Track 8-7Nanopores
- Track 9-1Biopharmaceutics and drug disposition
- Track 9-2Pharmaceutical technology
- Track 9-3Innovations in clinical development
- Track 9-4Pharmaceutics and drug delivery
- Track 9-5Drug discovery and design
- Track 9-6Routes of administration
- Track 9-7Pre formulation studies
The global market for Bioinformatics is expected to grow from nearly $2.3 billion in 2014 to nearly $3.4 billion in 2019, with a compound annual growth rate (CAGR) of 8.3% for the period of 2014-2019.
- Track 10-1 Bioinformatics and computational biology
- Track 10-2Biochips and bioinstrumentation
- Track 10-3Bioinformatics engineering
- Track 10-4Biolanguages
- Track 10-5Biomedical science and engineering
Genetics is the study of genes, heredity, and genetic variation in living beings. It is basically considered a field of biology, but it bisect often with many of the life sciences like Pharmaceutical Sciences. The other aspects of this are Genetic engineering, Biomedical Engineering, Genomics Proteomics, Clinical engineering, Tissue engineering, biomedical data engineering etc.
The global genetic engineering market is expected to reach $3,514.08 Million by 2019 from $1,845.25 Million in 2014, growing at a CAGR of 13.75%. Increased R&D expenditure and growth of biotechnology and pharmaceutical industries, increased funding for genomics research, and technological advancements are the primary growth drivers for this market during the forecast period (2014–2019).
- Track 11-1Genomics and proteomics in Pharmaceutical Industry
- Track 11-2Clinical engineering in Pharmaceutical Industry
- Track 11-3Tissue engineering in Pharmaceutical Industry
- Track 11-4Tissue engineering in Pharmaceutical Industry
- Track 11-5Tissue engineering in Pharmaceutical Industry
- Track 11-6Identification and classification of genes
Packaging is one of the largest industry sectors in the world, worth several billions. Pharmaceutical packaging represents a meagre percentage of this colossal market. The global healthcare industry has seen a shift in paradigm and is now skewed toward effective and meaningful packaging. Packaging was considered as an afterthought which was required merely in the final stages of manufacturing for many pharmaceutical companies about a decade ago.
- Track 12-1 Future of Packaging Materials
- Track 12-2Regulatory Considerations-China, US, EU, Pharmacopoeia
- Track 12-3EN 16679-Anti-Counterfeiting and Tamper Evidence Techniques
- Track 12-4Packaging for Patient Compliance
- Track 12-5Packing technology for Drug Delivery Systems
- Track 12-6Serialization implementation challenges for Pharma Companies
Radiopharmaceuticals used as Diagnostic and therapeutic agents. The main group of these compounds are used as the radio tracers to diagnose the diseased tissues in a body.
- Track 13-1Radiopharmaceutical Usage
- Track 13-2Bio-engineering in Pharmaceutical Industry
- Track 13-3Engineering models in biomedicine
- Track 13-4Bionic human
- Track 13-5Clinical laboratory sciences
- Track 13-6Biomedical data engineering
Pharma Companies in Europe - Kowa Pharmaceutical, Aegerion Pharmaceuticals Ltd, Kent Pharmaceuticals, Alan Pharmaceuticals, Alliance Pharmaceutical Limited. Pharmaceutical Companies are knowledge driven industry and is heavily dependent on Research and Development for new products and growth. However, basic research discovering of new molecules is a time consuming and expensive process and is thus, dominated by large global multinationals.
- Track 14-1Pharma Companies Europe
- Track 14-2Pharma Companies in Switzerland
- Track 14-3Generic Pharma Companies
- Track 14-4Global Pharmaceutical Companies
They are experts in the field of medicines and are not only responsible for the dispensing of prescriptions but also the purchase, manufacture and quality testing of all medicines used in a hospital. Many hospital pharmacists are qualified to prescribe in their own right. Pharmacists work closely with medical and nursing staff to ensure that patients receive the best treatment, advising on the selection, dose and administration route. They also provide help and advice to patients in all aspects of their medicines.
In 2013, there were 287,420 pharmacists and 362,690 pharmacy technicians in the United States. Since 2003, the number of pharmacists in the U.S. has fluctuated year to year, but overall has increased approximately 19 %in the last decade. The number of pharmacy technicians steadily increased in the same period, adding over 151,000 workers from 2003-2013.
- Track 15-1Drug Interactions
- Track 15-2Drug discovery and development
- Track 15-3Industrial pharmaceutics
- Track 15-4Pre-clinical studies
- Track 15-5Clinical studies
- Track 15-6Supply chain
Industrial Pharmacy also plays a crucial role in any drug discovery. To any novel drug discovery the industrial approach is very important to get massive commercial application. Few things which have to be considered by industries to provide a safe and cost affective medicine to the patients like Supply chain, Waste management, Product management, Post- marketing surveillance, Good manufacturing practices and Marketing.
The U.S. pharmaceutical market is the world’s most important national market. Together with Canada and Mexico, it represents the largest continental pharma market worldwide. TheUnited States alone holds some 40 percent of the global pharmaceutical market. In 2014, this share was valued around 365 million U.S. dollars. Many of the global top companies are located in the United States. In 2014, six out of the top eleven companies were U.S.-based.
- Track 16-1Waste management
- Track 16-2Product management
- Track 16-3Post- marketing surveillance
- Track 16-4Good manufacturing practices
- Track 16-5Pharmaceutical Marketing
- Track 16-6Pharma Manufacturing
- Track 17-1FDCA
- Track 17-2NDA
- Track 17-3Adulteration
- Track 17-4Misbranding
- Track 17-5Exemption in prescription
- Track 17-6Experimental animal ethics
- Track 17-7Human trial ethics
Nanomedicine is simply the nanotechnology applications in a healthcare setting and the majority of benefits that have already been seen involve the use of nanoparticles to improve the behaviour of drug substances and in drug delivery. Today, nanomedicines are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol,menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema. Nanomedicine has the potential to develop radical new therapies based on an unprecedented control over both intracellular processes and the extracellular environment at the nanometer scale. To create precise solutions for intricate medical challenges in the area of wound healing, tissue regeneration and mitochondrial disease physical scientists, medical doctors, and industrial partners, work closely in the Radboud Nanomedicine Alliance. The National Nanotechnology Initiative expects new commercial applications in the pharmaceutical industry that may include advanced delivery systems, new therapies, and in vivo imaging.
- Scope of Nanomedicine
- Future aspects of Nanomedicine
- Nanomedicine for Cardiovascular Diseases
- Nanomedicine for Lung Diseases
- Nanomedicine for blood disorders
- Nanomedicine for CNS
- Nanomedicine for Gastrointestinal Tract (GI) Diseases
- Nanomedicine for other disease
- Novel Drugs to Nano Drugs
- Nanodrugs for Herbal medicines and Cosmetics
- Track 18-1Future aspects of Nanomedicine
- Track 18-2Nanomedicine for Cardiovascular Diseases
- Track 18-3Novel Drugs to Nano Drugs
- Track 18-4Nanodrugs for Herbal medicines and Cosmetics
- Track 18-5Scope of Nanomedicine
The Pharma consultants work with organizations of all sizes including academic institutes, start-up companies, and established organizations. The services aims to increase the patient’s knowledge of their medication and improve their adherence to the regimen.
Globally Pharma Market ranges from $870-$900 billion and in Europe $260-$280 billion from which Germany provides ready access to internationally renowned scientists, world-class research and pharmaceuticals markets. Nanotechnology